XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Open Market Sale Agreement
Common Stock
Common Stock
Open Market Sale Agreement
Additional Paid In Capital
Additional Paid In Capital
Open Market Sale Agreement
Accumulated Deficit
Balance at Dec. 31, 2018 $ 155,007   $ 37   $ 220,240   $ (65,270)
Balance, Shares at Dec. 31, 2018     36,760,536        
Issuance of common stock upon exercise of stock options 25       25    
Issuance of common stock upon exercise of stock options, Shares     50,533        
Vesting of restricted stock and early exercised options 38       38    
Stock-based compensation expense 964       964    
Net loss and comprehensive loss (11,733)           (11,733)
Balance at Mar. 31, 2019 144,301   $ 37   221,267   (77,003)
Balance, Shares at Mar. 31, 2019     36,811,069        
Balance at Dec. 31, 2018 155,007   $ 37   220,240   (65,270)
Balance, Shares at Dec. 31, 2018     36,760,536        
Net loss and comprehensive loss (25,786)            
Balance at Jun. 30, 2019 131,846   $ 37   222,865   (91,056)
Balance, Shares at Jun. 30, 2019     36,871,175        
Balance at Mar. 31, 2019 144,301   $ 37   221,267   (77,003)
Balance, Shares at Mar. 31, 2019     36,811,069        
Issuance of common stock upon exercise of stock options 87       87    
Issuance of common stock upon exercise of stock options, Shares     34,480        
Issuance of common stock under employee stock plans 308       308    
Issuance of common stock under employee stock plans, Shares     25,626        
Vesting of restricted stock and early exercised options 37       37    
Stock-based compensation expense 1,166       1,166    
Net loss and comprehensive loss (14,053)           (14,053)
Balance at Jun. 30, 2019 131,846   $ 37   222,865   (91,056)
Balance, Shares at Jun. 30, 2019     36,871,175        
Balance at Dec. 31, 2019 171,427   $ 38   274,494   (103,105)
Balance, Shares at Dec. 31, 2019     38,040,693        
Issuance of common stock upon exercise of stock options 192       192    
Issuance of common stock upon exercise of stock options, Shares     39,393        
Issuance of common stock in at-the-market offering, net offering   $ 24,094   $ 1   $ 24,093  
Issuance of common stock in at-the-market offering, net offering, Shares       448,755      
Vesting of restricted stock and early exercised options 36       36    
Stock-based compensation expense 1,927       1,927    
Net loss and comprehensive loss (22,824)           (22,824)
Balance at Mar. 31, 2020 174,852   $ 39   300,742   (125,929)
Balance, Shares at Mar. 31, 2020     38,528,841        
Balance at Dec. 31, 2019 $ 171,427   $ 38   274,494   (103,105)
Balance, Shares at Dec. 31, 2019     38,040,693        
Issuance of common stock upon exercise of stock options, Shares 63,171            
Net loss and comprehensive loss $ (51,673)            
Balance at Jun. 30, 2020 149,311   $ 39   304,050   (154,778)
Balance, Shares at Jun. 30, 2020     38,561,026        
Balance at Mar. 31, 2020 174,852   $ 39   300,742   (125,929)
Balance, Shares at Mar. 31, 2020     38,528,841        
Issuance of common stock upon exercise of stock options 204       204    
Issuance of common stock upon exercise of stock options, Shares     23,778        
Issuance of common stock under employee stock plans 350       350    
Issuance of common stock under employee stock plans, Shares     8,407        
Vesting of restricted stock and early exercised options 36       36    
Stock-based compensation expense 2,718       2,718    
Net loss and comprehensive loss (28,849)           (28,849)
Balance at Jun. 30, 2020 $ 149,311   $ 39   $ 304,050   $ (154,778)
Balance, Shares at Jun. 30, 2020     38,561,026